Vargas, Andreza <br/><br/>
LHRH analog therapy is associated with worse metabolic side effects than bilateral orchiectomy in prostate cancer.  [electronic resource] 

 -  World journal of urology  Dec 2016 
 - 1621-1628 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1433-8726 
<br/><br/><label>Standard No.: </label>10.1007/s00345-016-1831-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Brazil--epidemiology<br/>Follow-Up Studies<br/>Gonadotropin-Releasing Hormone--analogs & derivatives<br/>Humans<br/>Incidence<br/>Insulin Resistance<br/>Male<br/>Metabolic Syndrome--chemically induced<br/>Middle Aged<br/>Orchiectomy--adverse effects<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--metabolism<br/>Risk Factors<br/>Testosterone--metabolism